Efficacy Evaluable Population News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy Evaluable Population. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Evaluable Population Today - Breaking & Trending Today

Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients with Treatment-Naïve Myelofibrosis at AACR 2023

Published: April 18, 2023

– At Week 24, 60mg of Selinexor in Combination with Ruxolitinib Achieved: 92% SVR35 and 78% TSS50 in Efficacy Evaluable Population, 79% SVR35 and 58% TSS50 in...

Source: prnewswire.com

Related Topics:

United StatesSouth KoreaUnited KingdomHong KongKyongsang BuktoHaris AliReshma RangwalaJohn MascarenhasAmerican Association For Cancer ResearchExchange CommissionInformation DepartmentIcahn School Of Medicine At Mount SinaiEuropean UnionPrnewswire Karyopharm Therapeutics IncKaryopharm Selective Inhibitor Of Nuclear ExportDrug AdministrationCompany To Host Investor WebcastCity Of Hope Comprehensive Cancer CenterKaryopharm Therapeutics IncSelective Inhibitor Of Nuclear ExportRuxolitinib AchievedEfficacy Evaluable PopulationTreat PopulationSustained Spleen Response AcrossRobust Symptom Improvement